Why did GAAP net income fall 36% despite strong adjusted earnings growth?

GAAP results are heavily affected by market-sensitive items that MetLife excludes from adjusted earnings. In 3Q25, net derivative losses of $929 million (versus a $767 million gain a year earlier) and net investment losses of $325 million drove the decline, partly offset by a $263 million market risk benefit remeasurement gain. Adjusted earnings, which strip out these volatile items, rose 15% to $1.58 billion.

Was the 3Q25 quarter boosted by one-time items?

Partly. The quarter included $18 million of net total notable items: an $89 million favorable annual actuarial assumption review, offset by a $71 million after-tax Mexican VAT charge recorded in Latin America. Excluding these, adjusted EPS was $2.34, still up 21%, so the underlying growth is not solely dependent on the notable items. Variable investment income, which was elevated by private equity returns, is a non-recurring-style driver that investors should monitor.

What is driving growth in the Asia segment?

Asia adjusted earnings rose 77% to $543 million, or 36% excluding notable items, mainly from higher variable investment income and volume growth. Sales were $786 million, up 34% on a constant currency basis, with Japan up 31% on new retirement-oriented products and Other Asia up 39%.

How strong is MetLife's capital position and shareholder return program?

MetLife returned about $875 million to shareholders in 3Q25, including roughly $500 million of buybacks and $375 million of dividends, with about $2.6 billion of year-to-date repurchases through October. Holding company cash and liquid assets were $4.9 billion, U.S. statutory adjusted capital was approximately $17.1 billion, and the expected Japan solvency margin ratio was about 740%. Management also guided to an estimated economic solvency ratio of 170% to 190% for March 2026.

METLIFE INC 8-K: Earnings & Results & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed November 5, 2025. Cited figures are marked; the original filing is the authoritative source.

MetLife (MET) reported third-quarter 2025 results on November 5, 2025, with net income available to common shareholders of $818 million^a, or $1.22 per diluted share, down 33% from $1.81 a year earlier.

The decline was driven mainly by a $929 million^b net derivative loss (versus a $767 million gain in 3Q24) and $325 million of net investment losses, partially offset by a $263 million market risk benefit remeasurement gain. Management's preferred performance gauge, adjusted earnings, rose 15% to $1.6 billion ($2.37 per share, up 22%), and excluding total notable items, adjusted EPS grew 21% to $2.34. Growth was led by higher variable investment income of $483 million, which came in well above the company's quarterly target, largely from private equity returns, and by strong Asia results.

Top-line growth was modest. Premiums, fees and other revenues were flat at $12.5 billion^c, while adjusted PFOs excluding pension risk transfers rose 4%. Net investment income rose 16% to $6.1 billion, though adjusted net investment income grew a more moderate 6%.

Asia was the standout segment, with adjusted earnings up 77% and sales up 34% on a constant currency basis, driven by Japan's new retirement-oriented products. Latin America adjusted earnings fell 33% on a Mexican value-added tax charge of $71 million^d after tax, although excluding notable items they rose 2%. RIS adjusted earnings declined 8% on a tough prior-year comparison, but ex-notables they grew 15%.

The quarter also included an $89 million favorable annual actuarial assumption review. Capital and balance-sheet positioning remain solid. Book value per share rose 1% to $39.52 and adjusted book value per share rose 3% to $56.57.

MetLife returned about $875 million to shareholders in the quarter through buybacks and dividends, and holding company cash and liquid assets were $4.9 billion. Management also highlighted $12 billion of pension risk transfer mandates secured in 4Q25 to date. Investors should weigh the strong underlying adjusted earnings momentum against the GAAP earnings decline, which is driven largely by market-sensitive derivative and investment items that management excludes from its adjusted measures.

02—Key points

Key Highlights

GAAP net income available to common shareholders fell 36% to $818 million ($1.22 per diluted share, down 33%), primarily due to a $929 million net derivative loss and $325 million of net investment losses.
Adjusted earnings rose 15% to $1.58 billion ($2.37 per share, up 22%); excluding total notable items, adjusted EPS grew 21% to $2.34.
Variable investment income reached $483 million (up 198%), well above the quarterly target of $425 million, driven by higher private equity returns.
Asia adjusted earnings surged 77% to $543 million, and sales grew 34% on a constant currency basis, with Japan up 31% on new retirement-oriented products.
Latin America adjusted earnings fell 33% to $147 million due to a $71 million after-tax Mexican VAT tax charge, though underlying earnings rose 2% excluding notable items.
Book value per share rose 1% to $39.52 and adjusted book value per share rose 3% to $56.57; returned approximately $875 million to shareholders and held $4.9 billion in holding company liquidity.
Secured $12 billion in pension risk transfer mandates in 4Q25 to date; 3Q25 direct expense ratio of 11.6% (ex-notables and PRT) came in below the 12.1% annual target.

03—Questions

Frequently Asked Questions

Why did GAAP net income fall 36% despite strong adjusted earnings growth?
GAAP results are heavily affected by market-sensitive items that MetLife excludes from adjusted earnings. In 3Q25, net derivative losses of $929 million (versus a $767 million gain a year earlier) and net investment losses of $325 million drove the decline, partly offset by a $263 million market risk benefit remeasurement gain. Adjusted earnings, which strip out these volatile items, rose 15% to $1.58 billion.
Was the 3Q25 quarter boosted by one-time items?
Partly. The quarter included $18 million of net total notable items: an $89 million favorable annual actuarial assumption review, offset by a $71 million after-tax Mexican VAT charge recorded in Latin America. Excluding these, adjusted EPS was $2.34, still up 21%, so the underlying growth is not solely dependent on the notable items. Variable investment income, which was elevated by private equity returns, is a non-recurring-style driver that investors should monitor.
What is driving growth in the Asia segment?
Asia adjusted earnings rose 77% to $543 million, or 36% excluding notable items, mainly from higher variable investment income and volume growth. Sales were $786 million, up 34% on a constant currency basis, with Japan up 31% on new retirement-oriented products and Other Asia up 39%.
How strong is MetLife's capital position and shareholder return program?
MetLife returned about $875 million to shareholders in 3Q25, including roughly $500 million of buybacks and $375 million of dividends, with about $2.6 billion of year-to-date repurchases through October. Holding company cash and liquid assets were $4.9 billion, U.S. statutory adjusted capital was approximately $17.1 billion, and the expected Japan solvency margin ratio was about 740%. Management also guided to an estimated economic solvency ratio of 170% to 190% for March 2026.

04—Continue

← View all 8-K filings